Opportunity ID: 340174

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-22-183
Funding Opportunity Title: Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.273 — Alcohol Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 09, 2022
Last Updated Date: Nov 20, 2024
Original Closing Date for Applications: Mar 21, 2025
Current Closing Date for Applications: Nov 21, 2024
Archive Date: Dec 21, 2024
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Private institutions of higher education
Small businesses
State governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
Special district governments
Public and State controlled institutions of higher education
County governments
For profit organizations other than small businesses
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and adherence interventions; (3) drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability and sustainability; (4) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (5) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (6) interventions to treat substance misuse and chronic pain. Research of interest includes but is not limited to Stage I research.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-22-183.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date
updated close date Nov 20, 2024
May 09, 2022

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-22-183
Funding Opportunity Title: Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.273 — Alcohol Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 09, 2022
Last Updated Date: Nov 20, 2024
Original Closing Date for Applications: Mar 21, 2025
Current Closing Date for Applications: Nov 21, 2024
Archive Date: Dec 21, 2024
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Private institutions of higher education
Small businesses
State governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
Special district governments
Public and State controlled institutions of higher education
County governments
For profit organizations other than small businesses
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description:

The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and adherence interventions; (3) drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability and sustainability; (4) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (5) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (6) interventions to treat substance misuse and chronic pain. Research of interest includes but is not limited to Stage I research.

Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-22-183.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-22-183
Funding Opportunity Title: Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.273 — Alcohol Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 09, 2022
Last Updated Date: May 09, 2022
Original Closing Date for Applications:
Current Closing Date for Applications: Mar 21, 2025
Archive Date: Apr 26, 2025
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public housing authorities/Indian housing authorities
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
Native American tribal governments (Federally recognized)
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
City or township governments
Public and State controlled institutions of higher education
For profit organizations other than small businesses
Special district governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and adherence interventions; (3) drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability and sustainability; (4) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (5) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (6) interventions to treat substance misuse and chronic pain. Research of interest includes but is not limited to Stage I research.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-22-183.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00274097 Jul 10, 2022 Nov 21, 2024 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00278284 Nov 10, 2022 Nov 21, 2024 View
FORMS-I Use for due dates on or after January 25, 2025 PKG00289008 Nov 25, 2024 Mar 21, 2025 View

Package 1

Mandatory forms

340174 RR_SF424_5_0-5.0.pdf

340174 PHS398_CoverPageSupplement_5_0-5.0.pdf

340174 RR_OtherProjectInfo_1_4-1.4.pdf

340174 PerformanceSite_4_0-4.0.pdf

340174 RR_KeyPersonExpanded_4_0-4.0.pdf

340174 PHS398_ResearchPlan_4_0-4.0.pdf

340174 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

340174 RR_Budget_3_0-3.0.pdf

340174 RR_SubawardBudget30_3_0-3.0.pdf

340174 PHS398_ModularBudget_1_2-1.2.pdf

340174 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

340174 RR_SF424_5_0-5.0.pdf

340174 PHS398_CoverPageSupplement_5_0-5.0.pdf

340174 RR_OtherProjectInfo_1_4-1.4.pdf

340174 PerformanceSite_4_0-4.0.pdf

340174 RR_KeyPersonExpanded_4_0-4.0.pdf

340174 PHS398_ResearchPlan_5_0-5.0.pdf

340174 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

340174 RR_Budget_3_0-3.0.pdf

340174 RR_SubawardBudget30_3_0-3.0.pdf

340174 PHS398_ModularBudget_1_2-1.2.pdf

340174 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

340174 RR_SF424_5_0-5.0.pdf

340174 PHS398_CoverPageSupplement_5_0-5.0.pdf

340174 RR_OtherProjectInfo_1_4-1.4.pdf

340174 PerformanceSite_4_0-4.0.pdf

340174 RR_KeyPersonExpanded_4_0-4.0.pdf

340174 PHS398_ResearchPlan_5_0-5.0.pdf

340174 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

340174 RR_Budget_3_0-3.0.pdf

340174 RR_SubawardBudget30_3_0-3.0.pdf

340174 PHS398_ModularBudget_1_2-1.2.pdf

340174 PHS_AssignmentRequestForm_4_0-4.0.pdf

2025-07-13T05:19:57-05:00

Share This Post, Choose Your Platform!

About the Author: